Novartis Czech Republic - Net Profit

Novartis Czech Republic`s Net Profit reached 71.0 CZK mil in 2017. This is 6.08 % less than in the previous year.

$1.99

Buy Net Profit data for Novartis Czech Republic.

$19.99

Buy all data for Novartis Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic ... ... ... ... ...             46.2 28.3 28.7 40.5 35.8    
Bayer Czech Republic ... ... ...                 166 83.4 96.2 107 123    
GlaxoSmithKline Czech Republic ... ... ...                 240 164 127 87.7 125    
Merck Czech Republic ... ...                   49.3 63.4 27.4 34.9 68.6    
Novartis Czech Republic                       41.7 50.0 52.3 82.2 82.7    
Pfizer Czech Republic ... ...                   231 48.1 144 134 75.4    
Roche Czech Republic ... ... ...                 50.5 38.7 135 94.9 51.0   ...
Sanofi-Aventis Czech Republic ... ... ... ...               55.1 45.2 65.2 1.19 58.6    
Servier Czech Republic ... ... ... ... ... ... ... ... ... ... ... ... 12.8 13.6 13.6 15.9    
Walmark ... ... ...                 214 -3.00 -8.61 41.8 -716